Method of treating atherosclerosis, dyslipidemias and related conditions and pharmaceutical compositions

Details for Australian Patent Application No. 2004240597 (hide)

Owner Merck Frosst Canada Ltd. Merck Sharp & Dohme Corp.

Inventors Waters, M. Gerard; O'Neill, Gary; Metters, Kathleen M.; Cheng, Kang

Agent A J Park

Pub. Number AU-B-2004240597

PCT Pub. Number WO2004/103370

Priority 60/470,665 15.05.03 US

Filing date 13 May 2004

Wipo publication date 2 December 2004

Acceptance publication date 6 January 2011

International Classifications

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 31/00 (2006.01)

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61K 31/437 (2006.01)

A61K 31/4745 (2006.01)

A61K 31/538 (2006.01)

A61K 31/69 (2006.01) - Boron compounds

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

Event Publications

10 November 2005 PCT application entered the National Phase

  PCT publication WO2004/103370 Priority application(s): WO2004/103370

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Frosst Canada Ltd.; Merck Sharp & Dohme Corp. 2005

6 January 2011 Application Accepted

  Published as AU-B-2004240597

12 May 2011 Standard Patent Sealed

4 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Frosst Canada Ltd; Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004240608-Orthodontic expansion appliance

2004240592-Echogenic stent